Wedge Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Wedge Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,400	Closed	-$300K	–	620
2014 Q4	$300K	Buy	18,400 +4,500	+32%	+$82.6K	﹤0.01%	521
2014 Q3	$307K	Sell	13,900 -3,200	-19%	-$65.5K	﹤0.01%	514
2014 Q2	$344K	Sell	17,100 -1,000	-6%	-$16.9K	﹤0.01%	486
2014 Q1	$336K	Sell	18,100 -11,000	-38%	-$151K	﹤0.01%	416
2013 Q4	$293K	Buy	29,100 +6,600	+29%	+$79.8K	﹤0.01%	446
2013 Q3	$290K	Buy	22,500 +800	+4%	+$9.84K	﹤0.01%	410
2013 Q2	$258K	Buy	+21,700	New	+$235K	﹤0.01%	434

Other funds holding AMRI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Wedge Capital Management's AMRI Position: Q1 2015 in Review

Wedge Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 18,400 shares — an estimated $300K sold.

Wedge Capital Management first reported a position in AMRI in Q2 2013 and held it in 7 quarters. The position peaked at $344K in Q2 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

Wedge Capital Management reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
Wedge Capital Management sold 18,400 Albany Molecular Research Inc shares in Q1 2015, an estimated $300K.
Wedge Capital Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 7 quarters.
Wedge Capital Management's Albany Molecular Research Inc position peaked at $344K in Q2 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Wedge Capital Management's 13F filing for Q1 2015, filed 1 May 2015.